Dr. Michelle McMurry-Heath's Testimony to Senate Finance Committee on USMCA
July 27, 2021
Chairman Wyden, Ranking Member Crapo, Members of the Committee, my name is Dr. Michelle McMurry-Heath. I am the President and CEO of the Biotechnology Innovation Organization (BIO). I am honored to testify before you for today’s hearing, Implementation and Enforcement of the United States – Mexico – Canada Agreement: One Year After Entry into Force and address our industry’s concerns around the implementation of the agricultural biotechnology provisions of the United States – Mexico – Canada Agreement or USMCA.
BIO and the American Seed Trade Association submitted comments on USDA-APHIS' proposed exemptions of five types of genetic modifications a plant can contain and be exempt from regulations for the movement of organisms modified or produced through…
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill.
Chairman Wyden, Ranking Member Crapo, Members of the Committee, my name is Dr. Michelle McMurry-Heath. I am the President and CEO of the Biotechnology Innovation Organization (BIO). I am honored to testify before you for today’s hearing, Implementation and Enforcement of the United States – Mexico – Canada Agreement: One Year After Entry into Force and address our industry’s concerns around the implementation of the agricultural biotechnology provisions of the United States – Mexico – Canada Agreement or USMCA.